Take Action to Protect Medicare, Patients and Access to Innovation

Some members of Congress are targeting the biopharmaceutical industry as part of the larger reconciliation bill by proposing significant changes to Medicare and the commercial market that would negatively impact the industry and undermine the programs that provide critical access to medicines for millions of Americans. As an industry, we must act now and tell Congress to protect Medicare, patients and our economy. We urge you to contact your members of Congress now. Please fill out the form below to send a letter to your members of Congress.